Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Add-on in Bipolar Mania
NCT00250367Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 1997
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in bipolar disorder (BD), sponsored by Janssen Pharmaceutical. Started Oct 1997; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00250367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250367.